What are the potential interactions between Lamictal (lamotrigine) and Remeron (mirtazapine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lamotrigine and Mirtazapine Interactions

There are no significant pharmacokinetic interactions between lamotrigine (Lamictal) and mirtazapine (Remeron), making this combination safe to use without dosage adjustments for most patients. 1

Pharmacological Properties and Interaction Profile

Lamotrigine

  • Mechanism: Phenyltriazine derivative that inhibits sodium and calcium channels in presynaptic neurons, stabilizing neuronal membranes 2
  • Metabolism: Primarily through glucuronidation, not significantly through cytochrome P450 pathways 3
  • Known interactions:
    • Combined hormonal contraceptives may decrease lamotrigine levels 4
    • Valproic acid significantly decreases lamotrigine clearance (by 66% in bitherapy) 3
    • Carbamazepine and phenytoin increase lamotrigine clearance (by 52% and 96% respectively) 3

Mirtazapine

  • Mechanism: Noradrenergic and specific serotonergic antidepressant (NaSSA) with dose-dependent effects 1
  • Metabolism: Extensively metabolized in the liver via CYP1A2, CYP2D6, and CYP3A4 5
  • In vitro studies suggest mirtazapine is unlikely to cause clinically significant drug-drug interactions 5

Safety of the Combination

  1. No direct pharmacokinetic interaction

    • Guidelines do not list any interaction between lamotrigine and mirtazapine 4
    • Lamotrigine does not significantly affect or is affected by mirtazapine's metabolism pathways 1
  2. No evidence of serotonin syndrome risk

    • Unlike some antidepressant combinations, lamotrigine and mirtazapine together do not increase risk of serotonin syndrome 4
    • Mirtazapine has minimal serotonergic side effects compared to SSRIs 1

Clinical Considerations

Potential Benefits of the Combination

  • May be beneficial for patients with:
    • Bipolar depression (lamotrigine) with comorbid anxiety and sleep disturbance (mirtazapine) 1, 2
    • Epilepsy requiring mood stabilization and treatment for depression 3

Monitoring Recommendations

  • Monitor for common side effects of each medication:

    • Lamotrigine: Headache, nausea, infection, insomnia 2
    • Mirtazapine: Somnolence (54%), increased appetite (17%), weight gain (10%), dry mouth (25%) 1
  • Pay special attention to:

    • Sedation effects, especially when initiating treatment, as mirtazapine can cause significant sedation particularly at lower doses (7.5-15mg) 1
    • Weight changes, as mirtazapine can stimulate appetite and cause weight gain 1

Dosing Considerations

  • Lamotrigine requires slow titration (over 6 weeks) to minimize risk of serious rash 2
  • Mirtazapine dosing is typically 15-45mg daily, with lower doses (7.5-15mg) producing more sedation due to H1 receptor antagonism 1
  • No dose adjustments are needed when using these medications together 1

Important Precautions

  1. Avoid adding other interacting medications

    • Adding valproic acid would require lamotrigine dose reduction 3
    • Adding carbamazepine or phenytoin would require lamotrigine dose increase 3
    • Avoid MAOIs with mirtazapine due to risk of serotonin syndrome 4
  2. Monitor for rare but serious adverse effects

    • Lamotrigine: Serious rash including Stevens-Johnson syndrome (risk 0.1%) 2
    • Mirtazapine: Rare hematological effects such as agranulocytosis and neutropenia 1

Conclusion

The combination of lamotrigine and mirtazapine is pharmacologically compatible with no significant drug interactions requiring dose adjustments. This combination may be particularly useful for patients with mood disorders who require both mood stabilization and treatment for depression with anxiety or sleep disturbances.

References

Guideline

Antidepressant Medication Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.